Targeting galectin-3 in inflammatory and fibrotic diseases
Trends in Pharmacological Sciences · 2023-08 · 44 (8) · 519-531
DOI: 10.1016/j.tips.2023.06.001 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-08. Verfasst von Selena Bouffette und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France; Université Paris-Saclay, Inserm, Inflammatio…. Hauptthemen laut MEDLINE: Galectin 3, COVID-19. Die Arbeit wurde bisher 175-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France; Université Paris-Saclay, Inserm, Inflammation Microbiome and Immunosurveillance, Orsay, France.
- Servier, Drug Design Small Molecules Unit, Servier R&D Center, Gif-sur-Yvette, France.
- Servier, Neurology and Immuno-inflammation Therapeutic Area, Servier R&D Center, Gif-sur-Yvette, France. Electronic address: frederic.deceuninck@servier.com.
Zitieren
APA
Bouffette, S., Botez, I., & De Ceuninck, F. (2023). Targeting galectin-3 in inflammatory and fibrotic diseases. Trends in Pharmacological Sciences, 44(8), 519-531. https://doi.org/10.1016/j.tips.2023.06.001
Vancouver
Bouffette S, Botez I, De Ceuninck F. Targeting galectin-3 in inflammatory and fibrotic diseases. Trends in Pharmacological Sciences. 2023;44(8):519-531. doi:10.1016/j.tips.2023.06.001
BibTeX
@article{Bouffette2023,
author = {Bouffette, Selena and Botez, Iuliana and De Ceuninck, Frédéric},
title = {Targeting galectin-3 in inflammatory and fibrotic diseases},
journal = {Trends in Pharmacological Sciences},
year = {2023},
volume = {44},
number = {8},
pages = {519--531},
doi = {10.1016/j.tips.2023.06.001}
}
EUVIMED